Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-11 Sale |
2024-03-12 8:01 pm |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
183,238 | $3.1694 | $580,760 | 2,552,499 (Direct) |
View |
| 2022-06-23 Purchase |
2022-06-27 06:41 am |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
17,700 | $3.3642 | $59,546 | 1,216,535 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-04 Option Award |
2025-03-06 4:17 pm |
N/A 2035-03-03 |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
809,710 | $0 | 809,710 (Direct) |
View |
| 2025-01-28 Option Award |
2025-01-29 4:30 pm |
N/A 2035-01-27 |
Evoke Pharma Inc | EVOK | Brady Todd C Director |
5,833 | $0 | 5,833 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-24 4:53 pm |
N/A 2034-05-21 |
Evoke Pharma Inc | EVOK | Brady Todd C Director |
14,625 | $0 | 14,625 (Direct) |
View |
| 2024-03-09 Option Award |
2024-03-12 8:01 pm |
N/A 2034-03-08 |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
1,081,201 | $0 | 2,552,499 (Direct) |
View |
| 2023-09-07 Exercise |
2023-09-11 5:42 pm |
N/A 2023-09-07 |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
273,058 | $0 | 1,654,536 (Direct) |
View |
| 2023-09-07 Exercise |
2023-09-11 5:42 pm |
N/A N/A |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
273,058 | $0.552 | 1,654,536 (Direct) |
View |
| 2023-09-07 Tax Withholding |
2023-09-11 5:42 pm |
N/A N/A |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
73,807 | $7.22 | 1,654,536 (Direct) |
View |
| 2023-05-10 Option Award |
2023-05-11 4:44 pm |
N/A 2033-05-09 |
Evoke Pharma Inc | EVOK | Brady Todd C Director |
14,625 | $0 | 14,625 (Direct) |
View |
| 2023-03-08 Equity Swap |
2023-03-09 09:17 am |
N/A N/A |
F-star Therapeutics Inc. | FSTX | Brady Todd C Director |
15,004 | $7.12 | 0 (Direct) |
View |
| 2020-11-20 Other |
2023-03-09 09:17 am |
N/A 2026-07-27 |
F-star Therapeutics Inc. | FSTX | Brady Todd C Director |
47,964 | $0 | 0 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 4:22 pm |
N/A 2033-02-27 |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
488,750 | $0 | 1,705,285 (Direct) |
View |
| 2022-07-15 Option Award |
2022-07-19 4:34 pm |
N/A N/A |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
604,308 | $0 | 604,308 (Direct) |
View |
| 2022-06-17 Option Award |
2022-06-22 5:15 pm |
N/A 2032-06-17 |
F-star Therapeutics Inc. | FSTX | Brady Todd C Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-04-27 Option Award |
2022-04-28 7:07 pm |
N/A 2032-04-26 |
Evoke Pharma Inc | EVOK | Brady Todd C Director |
57,750 | $0 | 57,750 (Direct) |
View |
| 2022-03-30 Option Award |
2022-04-01 7:44 pm |
N/A 2032-03-29 |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
457,758 | $0 | 1,656,593 (Direct) |
View |
| 2021-05-05 Option Award |
2021-07-23 6:15 pm |
N/A 2031-05-04 |
Evoke Pharma Inc | EVOK | Brady Todd C Director |
57,750 | $0 | 57,750 (Direct) |
View |
| 2021-06-04 Option Award |
2021-06-07 4:14 pm |
N/A 2031-06-04 |
F-star Therapeutics Inc. | FSTX | Brady Todd C Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-04-12 Option Award |
2021-04-14 7:23 pm |
N/A 2031-04-11 |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
296,619 | $0 | 1,198,835 (Direct) |
View |
| 2020-11-19 Other |
2020-11-23 11:17 am |
2017-05-24 2021-11-23 |
F-star Therapeutics Inc. | SBPH | Brady Todd C Director |
2,741 | $0 | 0 (Direct) |
View |
| 2020-09-30 Option Award |
2020-10-01 4:00 pm |
N/A N/A |
Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director |
9,235 | $0 | 60,016 (Direct) |
View |
| 2020-06-30 Option Award |
2020-07-01 4:00 pm |
N/A N/A |
Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director |
8,418 | $0 | 50,781 (Direct) |
View |
| 2020-06-24 Option Award |
2020-06-25 4:00 pm |
N/A 2030-06-23 |
Spring Bank Pharmaceuticals Inc. | SBPH | Brady Todd C Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2020-05-27 Option Award |
2020-05-29 4:42 pm |
N/A 2030-05-26 |
Evoke Pharma Inc | EVOK | Brady Todd C Director |
57,750 | $0 | 57,750 (Direct) |
View |